Method for alleviating pulmonary fibrosis using epidermal growth factor
AssigneesWenzhou Prarucom Bio-Chemical Technology Co., Puhsin Ltd.
InventorsLe-Shin CHANG, Shang-Yu CHIA
Life of this patent
Estimating the term…
Loading patent…
AssigneesWenzhou Prarucom Bio-Chemical Technology Co., Puhsin Ltd.
InventorsLe-Shin CHANG, Shang-Yu CHIA
Estimating the term…
A method for alleviating pulmonary fibrosis includes administering to a subject in need thereof a composition containing epidermal growth factor. The composition further contains a polysaccharide and hyaluronic acid. Epidermal growth factor, the polysaccharide, and hyaluronic acid are present in a weight ratio ranging from 1:0.5:12.5 to 1:250:1250. Epidermal growth factor can exhibit satisfactory efficacy in alleviating pulmonary fibrosis and PF-related tissue lesions, and this efficacy can be enhanced when epidermal growth factor is used in combination with the polysaccharide and hyaluronic acid.
A method for alleviating pulmonary fibrosis, comprising administering to a subject in need thereof a composition containing epidermal growth factor.
10-25. (canceled)
Dependencies are inferred from the claim text.